Aaronson, N.K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N.J., Filiberti, A., Flechtner, H., et al.: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. JNCI J. Natl. Cancer Inst. 85(5), 365–376 (1993). https://doi.org/10.1093/jnci/855
Abdin, E., Chong, S.A., Seow, E., Peh, C.X., Tan, J.H., Liu, J., Hui, S.F.S., Chua, B.Y., et al.: A comparison of the reliability and validity of SF-6D, EQ-5D and HUI3 utility measures in patients with schizophrenia and patients with depression in Singapore. Psychiatr. Res. 274, 400–408 (2019)
Ameri, H., Poder, T.G.: Valuing SF-6Dv2 using a discrete choice experiment in a general population in Quebec, Canada. Int. J. Health Policy Manag. 13, 8404 (2024)
Article PubMed PubMed Central Google Scholar
Bland, J.M., Altman, D.G.: Statistical methods for assessing agreement between two methods of clinical measurement. Int. J. Nurs. Stud. 47(8), 931–936 (2010)
Brazier, J.E., Roberts, J.: The estimation of a preference-based measure of health from the SF-12. Med. Care 42(9), 851–859 (2004)
Brazier, J., Roberts, J., Deverill, M.: The estimation of a preference-based measure of health from the SF-36. J. Health Econ. 21(2), 271–292 (2002)
Brazier, J., Ratcliffe, J., Saloman, J., Tsuchiya, A.: Measuring and Valuing Health Benefits for Economic Evaluation. Oxford University Press, Oxford (2017)
Brazier, J.E., Mulhern, B.J., Bjorner, J.B., Gandek, B., Rowen, D., Alonso, J., Vilagut, G., Ware, J.E.: Developing a new version of the SF-6D health state classification system from the SF-36v2: SF-6Dv2. Med. Care 58(6), 557–565 (2020)
Cadth, Z.: Guidelines for the Economic Evaluation of Health Technologies. CADTH Ottawa, Canada (2017)
Cella, D.F., Tulsky, D.S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S.B., et al.: The functional assessment of cancer therapy scale: development and validation of the general measure. J. Clin. Oncol. 11(3), 570–579 (1993)
Cohen, J.: Statistical Power Analysis for the Behavioral Sciences. Routledge, London (2013)
Daroudi, R., Zeraati, H., Poder, T.G., Norman, R., Olyaeemanesh, A., Sari, A.A., Ameri, H.: Valuing the SF-6Dv2 in the capital of Iran using a discrete choice experiment with duration. Qual. Life Res. 33(7), 1853–1863 (2024)
Deyo, R.A., Diehr, P., Patrick, D.L.: Reproducibility and responsiveness of health status measures statistics and strategies for evaluation. Control. Clin. Trials 12(4), S142–S158 (1991)
Farag, I., Sherrington, C., Kamper, S., Ferreira, M., Moseley, A., Lord, S., Cameron, I.: Measures of physical functioning after hip fracture: construct validity and responsiveness of performance-based and self-reported measures. Age Ageing 41(5), 659–664 (2012)
Feng, Y.-S., Kohlmann, T., Janssen, M.F., Buchholz, I.: Psychometric properties of the EQ-5D-5L: a systematic review of the literature. Qual. Life Res. 30, 647–673 (2021)
Finch, A.P., Brazier, J.E., Mukuria, C.: What is the evidence for the performance of generic preference-based measures? A systematic overview of reviews. Eur. J. Health Econ. 19, 557–570 (2018)
Gaujoux-Viala, C., Rat, A.-C., Guillemin, F., Flipo, R.-M., Fardellone, P., Bourgeois, P., Fautrel, B.: Responsiveness of EQ-5D and SF-6D in patients with early arthritis: results from the ESPOIR cohort. Ann. Rheum. Dis. 71(9), 1478–1483 (2012)
Group TE: EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 16(3), 199–208 (1990)
Guyatt, G.H., Feeny, D.H., Patrick, D.L.: Measuring health-related quality of life. Ann. Intern. Med. 118(8), 622–629 (1993)
Hays, R.D., Kallich, J.D., Mapes, D.L., Coons, S.J., Carter, W.B.: Development of the kidney disease quality of life (KDQOLTM) instrument. Qual. Life Res. 3(5), 329–338 (1994)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., Badia, X.: Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual. Life Res. 20, 1727–1736 (2011)
Article PubMed PubMed Central Google Scholar
Horsman, J., Furlong, W., Feeny, D., Torrance, G.: The health utilities index (HUI®): concepts, measurement properties and applications. Health Qual. Life Outcomes 1, 1–13 (2003)
Kularatna, S., Senanayake, S., Gunawardena, N., Graves, N.: Comparison of the EQ-5D 3L and the SF-6D (SF-36) contemporaneous utility scores in patients with chronic kidney disease in Sri Lanka: a cross-sectional survey. BMJ Open 9(2), e024854 (2019)
Article PubMed PubMed Central Google Scholar
Li, M., Fang, B., Gu, H., Jiang, Y.: EQ-5D-5L and SF-6Dv2 health utilities scores of diffuse large B-cell lymphoma patients in China. Health Qual. Life Outcomes 22(1), 80 (2024)
Article PubMed PubMed Central Google Scholar
McHorney, C.A., Tarlov, A.R.: Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual. Life Res. 4(4), 293–307 (1995)
McHugh, M.L.: Interrater reliability: the kappa statistic. Biochem. Med. 22(3), 276–282 (2012)
McTaggart-Cowan, H., King, M.T., Norman, R., Costa, D.S., Pickard, A.S., Regier, D.A., Viney, R., Peacock, S.J.: The EORTC QLU-C10D: the Canadian valuation study and algorithm to derive cancer-specific utilities from the EORTC QLQ-C30. MDM Policy Pract. 4(1), 2381468319842532 (2019)
Article PubMed PubMed Central Google Scholar
McTaggart-Cowan, H., King, M.T., Norman, R., Costa, D.S., Pickard, A.S., Viney, R., Peacock, S.J., Dean CMTCKHJLNMNR: The FACT-8D, a new cancer-specific utility algorithm based on the Functional Assessment of Cancer Therapies-General (FACT-G): a Canadian valuation study. Health Qual. Life Outcomes 20(1), 97 (2022)
Article PubMed PubMed Central Google Scholar
Moradi, N., Poder, T.G., Safari, H., Mojahedian, M.M., Ameri, H.: Psychometric properties of the EQ-5D-5L compared with EQ-5D-3L in cancer patients in Iran. Front. Oncol. 12, 1052155 (2022)
Article PubMed PubMed Central Google Scholar
Mulhern, B., Norman, R., Brazier, J.: Valuing SF-6Dv2 in Australia using an international protocol. Pharmacoeconomics 39, 1151–1162 (2021)
Nahvijou, A., Safari, H., Ameri, H.: Comparing the performance of the EQ-5D-5L with two versions of the SF-6Dv2 in patients with breast cancer. Health Serv. Outcomes Res. Methodol. 20, 183–194 (2020)
Nahvijou, A., Safari, H., Ameri, H.: Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population. Breast Cancer 28, 937–943 (2021)
Norman, G.R., Sloan, J.A., Wyrwich, K.W.: Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med. Care 41(5), 582–592 (2003)
Patrick, D.L., Deyo, R.A.: Generic and disease-specific measures in assessing health status and quality of life. Med. Care 27(3), S217–S232 (1989)
Pilz, M.J., Seyringer, S., Nerich, V., King, M.T., Norman, R., Gamper, E.M., Group EQoL: Validation of the cancer-specific preference-based measure EORTC QLU-C10D against the generic instruments EQ-5D-5L and SF-6Dv2 in a prospectively collected sample of patients with cancer in Austria and France. Pharmacoeconomics (2025). https://doi.org/10.1007/s40273-025-01501-3
Article PubMed PubMed Central Google Scholar
Poder, T.G., Carrier, N., McFadden, N., Pavic, M.: Health utilities in cancer patients: a study protocol for a prospective, longitudinal cohort using online survey. Medicine 98(9), e14647 (2019)
Comments (0)